Mass Tort brief
Roundup Settlement Push and Medical Device Verdicts Reshape Mass Tort Liabilities
Missouri court reviews $7.25B Roundup settlement as state enforcement and medical device verdicts reshape mass tort exposure.
Mass Tort
Bayer is trying to cap its endless weedkiller liabilities with a single payout — but plaintiffs fighting for individual jury trials could shatter the deal.
BackgroundBayer acquired Monsanto in 2018 and inherited tens of thousands of personal injury lawsuits linking glyphosate weedkillers to non-Hodgkin lymphoma. The German conglomerate has tried multiple legal frameworks to cap its compounding litigation liabilities.
- The proposed $7.25 billion settlement attempts to resolve roughly 65,000 pending personal injury claims and set up a medical monitoring fund.
- Objecting plaintiffs' attorneys argue the class action structure strips future cancer victims of their right to seek punitive damages in individual trials.
- Approval by the Missouri judge would establish a landmark liability cap, whereas rejection forces Bayer back into unpredictable state trial dockets.
Mass Tort
State attorneys general are joining the hair relaxer legal fight — opening a regulatory front that threatens L'Oréal with civil penalties beyond private injury settlements.
BackgroundThousands of women have brought private product liability suits alleging that long-term exposure to endocrine-disrupting chemicals in hair relaxers causes hormone-sensitive cancers. Federal claims are currently consolidated in Illinois under Multidistrict Litigation No. 3060.
- Arizona's enforcement action alleges L'Oréal violated state consumer protection laws by knowingly hiding severe health risks from consumers.
- The state demands civil penalties, financial restitution, and mandatory health warning labels on all hair straightening products sold in Arizona.
- State regulatory intervention adds government enforcement pressure alongside more than 12,000 private personal injury claims pending in federal court.
Mass Tort
A $40 million bellwether verdict destroys Becton Dickinson's defense posture — forcing the medical device maker to offer billions in global settlements or face ruinous trials.
BackgroundMultidistrict Litigation No. 3081 consolidates thousands of claims alleging Bard PowerPort devices suffer micro-fractures that lead to organ perforation, blood clots, and systemic infections. Bellwether trials serve as test cases to establish settlement values across consolidated mass tort litigation.
- The Phoenix federal jury awarded $40 million in compensatory damages to plaintiff Divelbliss after finding the catheter design unreasonably dangerous.
- Trial evidence demonstrated that high barium sulfate concentrations weakened the device's polyurethane material, causing internal fracturing under normal pressure.
- Nearly 4,000 product liability lawsuits against parent company Becton Dickinson remain pending in Arizona federal court awaiting resolution.
Mass Tort
Mass Tort
Mass Tort
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.
